Lisa M. Giles

Lisa M. Giles discloses dealings in 2 companies, chiefly GenMark Diagnostics, Inc. and HCW Biologics Inc. We count 13 filings; the first trade dates from 26 May 2016 and the latest from 20 February 2024.

On the market, this insider has only ever bought: 2 purchases, €8,439 in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 9 share grants.

The record was last updated on 22 February 2024 with a share grant (€46k) in HCW Biologics Inc. The last purchase on record was published on 22 August 2016, which is 3,714 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.